{
  "paper": "c46a8487dce2e8212eaa285c5663e248.txt",
  "words": 10852,
  "extractions": {
    "title": {
      "value": "Estimating individual treatment effect on disability progression in multiple sclerosis using deep learning",
      "justification": "The title clearly states the focus of the paper, which is on estimating the individual treatment effect on disability progression in multiple sclerosis using deep learning techniques.",
      "quote": "Estimating individual treatment effect on disability progression in multiple sclerosis using deep learning"
    },
    "description": "The paper proposes a deep-learning predictive enrichment strategy to enable more efficient phase 2 clinical trials for multiple sclerosis by using a multi-headed multilayer perceptron to estimate the conditional average treatment effect (CATE) based on baseline clinical and imaging features. This approach aims to increase statistical power in trials by preferentially randomizing predicted responders to treatment.",
    "type": {
      "value": "empirical",
      "justification": "The paper involves the use of empirical data from six randomized clinical trials to validate the proposed deep learning framework for estimating treatment effect.",
      "quote": "Leveraging data from six randomized clinical trials (n = 3,830), we first pre-trained the model..."
    },
    "primary_research_field": {
      "name": {
        "value": "Medical Imaging",
        "justification": "The research leverages medical imaging data, specifically MRI metrics, as part of the inputs for the deep learning model to assess treatment effect on disability progression in multiple sclerosis.",
        "quote": "a multi-headed multilayer perceptron is used to estimate the conditional average treatment effect (CATE) using baseline clinical and imaging features"
      },
      "aliases": [
        "Biomedical Imaging"
      ]
    },
    "sub_research_fields": [
      {
        "name": {
          "value": "Healthcare",
          "justification": "The application focus of the deep learning model is specifically on improving healthcare outcomes in terms of clinical trials for multiple sclerosis treatment.",
          "quote": "This approach, based on an ensemble of multi-headed multilayer perceptrons (MLPs), can identify more responsive individuals to both anti-CD20 monoclonal antibodies and laquinimod better than alternative strategies."
        },
        "aliases": []
      },
      {
        "name": {
          "value": "Causal Inference",
          "justification": "The paper focuses on using deep learning to infer the individual treatment effect, which is a causal inference problem.",
          "quote": "Adaptations to machine learning frameworks must therefore be made in order to frame the problem through the lens of causal inference."
        },
        "aliases": []
      }
    ],
    "models": [
      {
        "name": {
          "value": "Multi-headed multilayer perceptron (MLP)",
          "justification": "The paper introduces and uses a multi-headed multilayer perceptron model for estimating the conditional average treatment effect on disability progression.",
          "quote": "Specifically, a multi-headed multilayer perceptron is used to estimate the conditional average treatment effect (CATE) using baseline clinical and imaging features."
        },
        "aliases": [
          "MLP"
        ],
        "is_contributed": {
          "value": true,
          "justification": "The model is specifically developed and utilized in the study for estimating treatment effects.",
          "quote": "we present a new deep learning framework to estimate an individual’s treatment effect on disability progression using readily available clinical information..."
        },
        "is_executed": {
          "value": true,
          "justification": "The model was executed and evaluated using data from clinical trials.",
          "quote": "The model’s ability to rank response is assessed using an average difference curve..."
        },
        "is_compared": {
          "value": true,
          "justification": "The multi-headed MLP was compared to other baseline models.",
          "quote": "Comparison to baseline models... The MLP outperforms all other baselines on this metric."
        },
        "referenced_paper_title": {
          "value": "Deep counterfactual networks with propensity-dropout",
          "justification": "The paper references Alaa et al. in the context of similar model architecture but without the propensity network correction.",
          "quote": "Our network is similar to that conceptualized by Alaa et al., but without the propensity network..."
        }
      }
    ],
    "datasets": [
      {
        "name": {
          "value": "OPERA I",
          "justification": "Data from this clinical trial was used for training and evaluating the deep learning model.",
          "quote": "Data were pooled from six randomized clinical trials (n = 3830): OPERA I, OPERA II, BRAVO, ORATORIO, OLYMPUS, and ARPEGGIO"
        },
        "aliases": [],
        "role": "used",
        "referenced_paper_title": {
          "value": "Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis",
          "justification": "The OPERA I and OPERA II trials are likely referenced in context of ocrelizumab-related studies.",
          "quote": "OPERA I 8, OPERA II 8, BRAVO 9, ORATORIO 10, OLYMPUS 11, and ARPEGGIO 12..."
        }
      },
      {
        "name": {
          "value": "OPERA II",
          "justification": "Data from this clinical trial was used for training and evaluating the deep learning model.",
          "quote": "Data were pooled from six randomized clinical trials (n = 3830): OPERA I, OPERA II, BRAVO, ORATORIO, OLYMPUS, and ARPEGGIO"
        },
        "aliases": [],
        "role": "used",
        "referenced_paper_title": {
          "value": "Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis",
          "justification": "The OPERA I and OPERA II trials are likely referenced in context of ocrelizumab-related studies.",
          "quote": "OPERA I 8, OPERA II 8, BRAVO 9, ORATORIO 10, OLYMPUS 11, and ARPEGGIO 12..."
        }
      },
      {
        "name": {
          "value": "BRAVO",
          "justification": "Data from this clinical trial was used for training and evaluating the deep learning model.",
          "quote": "Data were pooled from six randomized clinical trials (n = 3830): OPERA I, OPERA II, BRAVO, ORATORIO, OLYMPUS, and ARPEGGIO"
        },
        "aliases": [],
        "role": "used",
        "referenced_paper_title": {
          "value": "A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis",
          "justification": "The BRAVO trial is referenced as part of the data for model development.",
          "quote": "OPERA I 8, OPERA II 8, BRAVO 9, ORATORIO 10, OLYMPUS 11, and ARPEGGIO 12..."
        }
      },
      {
        "name": {
          "value": "ORATORIO",
          "justification": "Data from this clinical trial was used for training and evaluating the deep learning model.",
          "quote": "Data were pooled from six randomized clinical trials (n = 3830): OPERA I, OPERA II, BRAVO, ORATORIO, OLYMPUS, and ARPEGGIO"
        },
        "aliases": [],
        "role": "used",
        "referenced_paper_title": {
          "value": "Ocrelizumab versus placebo in primary progressive multiple sclerosis",
          "justification": "The ORATORIO trial is specifically referenced when discussing results and model comparisons.",
          "quote": "OPERA I 8, OPERA II 8, BRAVO 9, ORATORIO 10, OLYMPUS 11, and ARPEGGIO 12..."
        }
      },
      {
        "name": {
          "value": "OLYMPUS",
          "justification": "Data from this clinical trial was used for training and evaluating the deep learning model.",
          "quote": "Data were pooled from six randomized clinical trials (n = 3830): OPERA I, OPERA II, BRAVO, ORATORIO, OLYMPUS, and ARPEGGIO"
        },
        "aliases": [],
        "role": "used",
        "referenced_paper_title": {
          "value": "Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial",
          "justification": "The OLYMPUS trial is mentioned as contributing to the data used in the study.",
          "quote": "OPERA I 8, OPERA II 8, BRAVO 9, ORATORIO 10, OLYMPUS 11, and ARPEGGIO 12..."
        }
      },
      {
        "name": {
          "value": "ARPEGGIO",
          "justification": "Data from this clinical trial was used for training and evaluating the deep learning model.",
          "quote": "Data were pooled from six randomized clinical trials (n = 3830): OPERA I, OPERA II, BRAVO, ORATORIO, OLYMPUS, and ARPEGGIO"
        },
        "aliases": [],
        "role": "used",
        "referenced_paper_title": {
          "value": "A randomized, placebo-controlled, phase 2 trial of laquinimod in primary progressive multiple sclerosis",
          "justification": "The ARPEGGIO trial data was used as a test set in the study.",
          "quote": "OPERA I 8, OPERA II 8, BRAVO 9, ORATORIO 10, OLYMPUS 11, and ARPEGGIO 12..."
        }
      }
    ],
    "libraries": [
      {
        "name": {
          "value": "PyTorch",
          "justification": "The PyTorch library was used for implementing the multi-headed MLP models.",
          "quote": "MLPs were implemented using the Pytorch library (version 1.7.1)"
        },
        "aliases": [],
        "role": "used",
        "referenced_paper_title": {
          "value": "PyTorch: an imperative style, high-performance deep learning library",
          "justification": "The referenced paper underpins the implementation framework used for the model.",
          "quote": "MLPs were implemented using the Pytorch library (version 1.7.1)"
        }
      }
    ]
  },
  "usage": {
    "completion_tokens": 1876,
    "prompt_tokens": 20928,
    "total_tokens": 22804,
    "completion_tokens_details": {
      "accepted_prediction_tokens": null,
      "audio_tokens": 0,
      "reasoning_tokens": 0,
      "rejected_prediction_tokens": null
    },
    "prompt_tokens_details": {
      "audio_tokens": 0,
      "cached_tokens": 1152
    }
  }
}